Case Report
Published on 21 Nov 2023
Treating seronegative neuromyelitis optica spectrum disorder with inebilizumab: a case report
in Multiple Sclerosis and Neuroimmunology
- 4,909 views
- 1 citation
Case Report
Published on 21 Nov 2023
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 17 Nov 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 16 Nov 2023
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 14 Nov 2023
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 06 Nov 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 02 Nov 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 26 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 26 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 23 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 19 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 19 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 19 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 12 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 10 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Study Protocol
Published on 10 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 06 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Hypothesis and Theory
Published on 06 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 04 Oct 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 29 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 28 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 26 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 21 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 15 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Sep 2023
in Multiple Sclerosis and Neuroimmunology